In X-linked nephrogenic diabetes insipidus (NDI) the urine of male patients is not concentrated after the administration ofthe antidiuretic hormone arginine-vasopressin. This disease is due to mutations in the V 2 receptor gene that maps to chromosome region Xq28. In 1969, Bode and Crawford suggested that most NDI patients in North America shared common ancestors of Ulster Scot immigrants who arrived in Halifax in 1761 on the ship Hopewell. A link between this family and a large Utah kindred was also suggested. DNA was obtained from 17 affected male patients from the "Hopewell" kindred and from four additional families from Nova Scotia and New Brunswick who shared the same Xq28 NDI haplotype. The Utah kindred and two families (Q2, Q3) from Quebec were also studied. The "Hopewell" mutation, W71X, is a single base substitution (G A) that changes codon 71 from TGG (tryptophan) to TGA (stop). The W71X mutation was found in affected members of the Hopewell and ofthe four satellite families. The W71X mutation is the cause of X-linked NDI for the largest number of related male patients living in North America. Other families (Utah, Q2 and Q3) that are historically and ethnically unrelated bear other mutations in the V2 receptor gene. (J.
and North America (4) (5) (6) in which the urine of affected patients does not concentrate after the administration of the antidiuretic hormone argi-nine vasopressin (7) . Bode and Crawford (4) studied a large extended kindred with NDI and described the history and folklore of "the water drinkers' curse." On the basis oftheir genealogical reconstructions, they proposed "the Hopewell hypothesis," that is, most cases of NDI in North America could be traced to descendants ofUlster Scots who arrived in Nova Scotia in 1761 on the ship Hopewell.
Caucasian (2) (3) (4) (5) (6) , African-American (6, (8) (9) (10) , and Australian aboriginal ( 11 ) families have been described with this disease. The NDI locus was mapped to the distal region of the long arm ofthe X-chromosome (Xq28) by linkage analysis (3, 6, 12, 13) . van den Ouweland et al. ( 14) reported that the NDI locus maps close to the color-vision pigment genes in Xq28 and have further localized the position between DXS52 and G6PD by using somatic cell hybrids. A candidate gene for NDI was the V2 receptor on the basis ofexamining V2 receptor binding activity and induction of cyclic-AMP production in response to vasopressin in somatic cell hybrids ( 15) . The molecular cloning and characterization of the V2 receptor in the human ( 16) and rat ( 17) have recently been accomplished. The sequence of the cDNA predicts a polypeptide of 371 amino acids that has seven transmembrane, four extracellular, and four cytoplasmic domains ( 16, 18) . The gene contains three exons and two small introns ( 19, 20) . The (6) . The Hopewell pedigree has been expanded (Fig. 1 a) (6) obligate carriers. Four additional extended families from Nova Scotia and New Brunswick were also studied ( Fig. 1 b) . During our visits (D. G. Bichet, M.-F. Arthus, M. Lonergan) to Halifax over the last 4 yr, patients and/or physicians brought to our attention these additional NDI patients living in the Maritime area. These families (Maritime: MI to M4) have Scottish ancestry and are not known to be related to each other or to the Hopewell kindred. For one family (M2) we were able to establish ancestry antedating the arrival of the ship Hopewell in 1761, but we were unable to link the ancestors to the original Bode and Crawford pedigree. Specifically, all the names and ancestors ofthe Hopewell pedigree (generations I to IV) are known from our previous study (6) ; none of these ancestors were found in the M2 pedigree. Family M4 has been previously described (23) . The phenotypic characteristics of the patients in families M2 through M4 were similar to those we previously described (24, 25) . In addition, five other unpublished pedigrees of X-linked NDI families were also studied.
Haplotype analysis. RFLP analysis of the probe/enzyme (and locus) combinations, St35-691 /TaqI (DXS305), DX13/BgIII (DXSJ5), and F814/BclI (F8C), and PCR analysis ofthe St14 VNTR (DXS52) were done as previously described (6). DNA sequencing. Genomic DNA was prepared from whole blood as previously described (6) . The AVPR2 gene was first amplified by nested PCR (Fig. 2) , with a PCR system (GeneAmp model 9600; Perkin Elmer Cetus Ltd., Montreal, P.Q., Canada). A general amplification protocol was done in a final volume of50 1l: initial denaturation at 980C for 5 min, addition of Taq polymerase (2 U/tube; Perkin Elmer Cetus Ltd.) denaturation at 940C for 2 min, and 30 cycles, each consisting of denaturation at 940C for 10 s, annealing at 620C for 15 s, and elongation at 720C for 60 s and a final extension at 720C for 10 min. The first PCR was done with 0.5 to 1 ytg ofgenomic DNA using primers 58 and 2 ( Fig. 2) , and the second ("nested") PCR with 3.5 M1 ofthe first PCR product using primers 62 and 63. The final 2-kb PCR product was amplified either by two different asymmetric PCRs using primers 64 and 65, or by subcloning into Bluescript KS (Stratagene Inc., La Jolla, CA) as previously described (21 Sequencing analysis of the AVPR2 gene in the Hopewell family identified a G-to-A transition at nucleotide position 284 (sequence numbering according to the GenBank entry Z1 1687 [17] ). The same mutation was present in affected patients of the Maritime families. These Maritime families are thus likely related to the Hopewell family and we call them "satellite" families. The nonsense mutation, W7 1X, which we will call the "Hopewell" mutation, leads to a predicted change of tryptophan (codon 71, TGG) to a stop codon (TGA) (Fig. 3) . The predicted protein truncated at codon 71 would lack six transmembrane domains, three extracellular domains, and three cytoplasmic domains (Fig. 4) . The W7 I X mutation was found in the DNA of all patients and obligate carriers studied ( Fig. 1) and not in the DNA of unaffected males.
The G-to-A transition of the W7 IX mutation creates a HgiAI as well as a DdeI restriction site. Results presented in Fig. 5 were done with BsiHKAI (isoschizomer of HgiAI), but similar data were obtained with DdeI. The W71X mutation also abolishes two restriction sites, those for NIaIV and BsrI. Only BsrI was tested on some individuals. Unaffected males were found to have the two predicted fragments (255 and 99 bp). Affected males had only one 354-bp product and carriers had the three fragments (there is a constant 73-bp band, data not shown). 
Leu iCTG CTG
BrSiOm ASO analysis was also used to test for the presence of the W7 l X mutation in affected patients and carriers. The normal sequence was found in both normal males and carriers, and the mutation was detected in patients and female carriers (Fig. 5) .
The W7 IX mutation was not found either by sequencing or by restriction enzyme analysis in the 12 other families we previously described (6) Three other mutations (Fig. 4) were identified by sequencing analysis in the Q2, Q3, and the Utah families (6) . The mutation identified in family Q3 is a C-to-T transition at nucleotide position 408 that leads to a predicted change of argi- RI 13W ). Another missense mutation was identified in family Q2, it is a G-to-A transition at nucleotide position 481 and leads to a predicted change of arginine (codon 137, CGC) to histidine (CAC) (RI 37H). A nonsense mutation was identified in the Utah kindred; it is a T-to-A transversion at nucleotide position 1006 and leads to a predicted change of leucine (codon 312, TTG) to a stop codon (TAG) (L312X). The RI13W and RI 37H missense mutations, both of which are in exon 2, alter the coding for amino acid residues predicted to be in the second extracellular domain and the second cytoplasmic domain, respectively. The L312X mutation is in exon 3, which is predicted to encode the seventh transmembrane domain and the fourth cytoplasmic domain.
Discussion
TheHopewell hypothesis. X-linked nephrogenic diabetes insipidus is a well-known disease in Nova Scotia and New Brunswick, with a prevalence of 24/1,000 males in certain well-defined communities. By contrast, the prevalence of NDI in the province of Quebec is only about 4/ 1,000,000 males (6) .
On the basis of genealogical data on NDI families, Bode and Crawford proposed a common origin of all North Ameri- can families affected with NDI (4) . A link between the Hopewell pedigree and Cannon's large Utah kindred was also suggested, based on the similarity of some surnames among the ancestors in the two pedigrees. The cloning ofthe AVPR2 gene and the identification of mutations that cause NDI allowed us to definitively test the hypothesis that Bode and Crawford doubted could ever be proved. The W7 IX mutation was found only in the Hopewell and satellite families. This is consistent with our previous haplotype analysis (6) and new haplotype data on the satellite families that show that all affected males tested in the Hopewell and satellite families share the same Xq28 haplotype 1-5-1-2. The four other North American families (Q2, Q3, Q5, and the Utah family) with identified mutations, each carry different mutations on different haplotypes. The members of the Hopewell and satellite families comprise the largest number of related male patients with X-linked NDI and living in North America. The fact that family M2 and the Hopewell kindred share the same mutation, despite the fact that they do not share known common ancestors, underscores the fact that the W7 IX mutation is not restricted to the pedigree published by Bode and Crawford. In accordance with our previous suggestion (6), these results confirm that carriers of the "Hopewell" mutation were prevalent in the Maritime area at the time of the landing of the ship Hopewell. Therefore, we anticipate that other NDI families, not known to be related to the Hopewell kindred, will be found carrying the W7 IX mutation.
Carrier detection. It is now possible to evaluate families with X-linked NDI by mutation analysis and/or haplotype analysis. In our studies there was a complete association between the W7 1X mutation and Stl4 VNTR (6). Our procedure is to first analyze the segregation of haplotypes by PCR analysis of the Stl4 VNTR. This is followed by HgiAI restriction enzyme analysis in families carrying the 1630-bp Stl4 VNTR allele. In other families, complete sequencing of the AVPR2 gene is done. In informative NDI families in which the mutation has not yet been identified, segregation of the Stl4 VNTR can be used for carrier detection (6) . Early diagnosis and treatment of male infants affected with NDI can avert the physical and mental retardation that are the consequences of episodes of dehydration.
The V2 receptor mutation repertoire. 16 mutations have now been reported ( Table I ). The majority of the mutations are clustered within the third extracellular loop, the third transmembrane domain, or the third intracellular loop (22) , which have previously been shown to be important for various functions, such as ligand binding and effector coupling, for other seven-membrane spanning receptors (27, 28). However, the W7 I X and L3 12X mutations lie outside these functionally important regions. This emphasizes that study of these naturally occurring mutations will be extremely helpful in pinpointing additional critical functional regions of the molecule. Truncated receptors generated by nonsense mutations like the W7IX and the L312X mutations will be nonfunctional (Fig.  4) , as expected from results obtained with the adrenergic receptor (29 (24, 25) . Patients with the mutations described here and by Rosenthal et al. (21 ) appear to have a uniform phenotype. In summary, the sequencing of the V2 receptor gene and mutation analysis of the Hopewell, Utah, and two French-Canadian NDI families have demonstrated the independent origin of NDI among these families. The W7 IX mutation was identified in 64 individuals, the largest known number of NDI patients and carriers in North America who share a V2 receptor mutation identical by descent. Carrier detection and early diagnosis of affected male infants are proposed.
